| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 50.85B | 42.08B | 44.43B | 44.52B | 57.82B |
| Gross Profit | 21.32B | 13.37B | 12.79B | 10.61B | 12.27B |
| EBITDA | 18.45B | 20.05B | 19.91B | 20.46B | 19.43B |
| Net Income | 11.03B | 9.56B | 8.45B | 9.14B | 8.71B |
Balance Sheet | |||||
| Total Assets | 451.84B | 419.54B | 405.98B | 398.33B | 376.21B |
| Cash, Cash Equivalents and Short-Term Investments | 33.41B | 25.34B | 28.42B | 27.91B | 28.23B |
| Total Debt | 264.55B | 245.68B | 222.67B | 222.04B | 202.24B |
| Total Liabilities | 325.07B | 301.54B | 280.33B | 279.01B | 256.93B |
| Stockholders Equity | 126.76B | 118.00B | 125.65B | 119.32B | 119.28B |
Cash Flow | |||||
| Free Cash Flow | -4.80B | -7.05B | 919.00M | -14.88B | 15.91B |
| Operating Cash Flow | 15.98B | 16.67B | 19.11B | 23.36B | 34.13B |
| Investing Cash Flow | -26.47B | -24.84B | -19.36B | -40.25B | -20.70B |
| Financing Cash Flow | 10.80B | 7.72B | 280.00M | 13.99B | -15.49B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥948.42B | 25.41 | 11.06% | 2.88% | 6.16% | 30.55% | |
78 Outperform | ¥4.55T | 18.13 | 10.15% | 1.86% | 24.11% | 62.02% | |
72 Outperform | ¥1.06T | 9.44 | 19.60% | 1.94% | 3.29% | 30.83% | |
71 Outperform | ¥5.23T | 11.76 | 7.67% | 1.18% | 7.12% | 25.01% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
62 Neutral | ¥1.22T | 13.23 | 19.43% | 5.16% | 7.73% | 4.60% | |
58 Neutral | ¥161.20B | 8.24 | 8.95% | 3.39% | 20.87% | 16.79% |